{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,26]],"date-time":"2026-09-26T07:06:22Z","timestamp":1790406382598,"version":"4.1.0"},"reference-count":110,"publisher":"MDPI AG","issue":"10","license":[{"start":{"date-parts":[[2021,9,22]],"date-time":"2021-09-22T00:00:00Z","timestamp":1632268800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/100006492","name":"Division of Intramural Research, National Institute of Allergy and Infectious Diseases","doi-asserted-by":"publisher","award":["ZIAAI001331"],"award-info":[{"award-number":["ZIAAI001331"]}],"id":[{"id":"10.13039\/100006492","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Pathogens"],"abstract":"<jats:p>Q fever is a zoonotic disease caused by the intracellular pathogen Coxiella burnetii. This disease typically manifests as a self-limiting, febrile illness known as acute Q fever. Due to the aerosol transmissibility, environmental persistence, and infectivity of C. burnetii, this pathogen is a notable bioterrorism threat. Despite extensive efforts to develop next-generation human Q fever vaccines, only one vaccine, Q-Vax\u00ae, is commercially available. Q-Vax\u00ae is a phase I whole-cell vaccine, and its licensed use is limited to Australia, presumably due to the potential for a post-vaccination hypersensitivity response. Pre-clinical Q fever vaccine development is a major area of interest, and diverse approaches have been undertaken to develop an improved Q fever vaccine. Following a brief history of Q fever vaccine development, current approaches will be discussed along with future considerations for an improved Q fever vaccine.<\/jats:p>","DOI":"10.3390\/pathogens10101223","type":"journal-article","created":{"date-parts":[[2021,9,26]],"date-time":"2021-09-26T22:24:13Z","timestamp":1632695053000},"page":"1223","update-policy":"https:\/\/doi.org\/10.3390\/mdpi_crossmark_policy","source":"Crossref","is-referenced-by-count":32,"title":["Q Fever Vaccine Development: Current Strategies and Future Considerations"],"prefix":"10.3390","volume":"10","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-5030-975X","authenticated-orcid":false,"given":"Carrie","family":"Long","sequence":"first","affiliation":[{"name":"Laboratory of Bacteriology, Division of Intramural Research, National Institute of Allergy and Infectious Disease, National Institutes of Health, Hamilton, MT 59828, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1968","published-online":{"date-parts":[[2021,9,22]]},"reference":[{"key":"ref_1","doi-asserted-by":"crossref","first-page":"297","DOI":"10.1016\/j.vetmic.2009.07.016","article-title":"Q Fever","volume":"140","author":"Angelakis","year":"2010","journal-title":"Vet. Microbiol."},{"key":"ref_2","doi-asserted-by":"crossref","first-page":"131932","DOI":"10.1155\/2012\/131932","article-title":"Q Fever: An Old but Still a Poorly Understood Disease","volume":"2012","author":"Honarmand","year":"2012","journal-title":"Interdiscip. Perspect. Infect. Dis."},{"key":"ref_3","doi-asserted-by":"crossref","first-page":"709","DOI":"10.1016\/S1473-3099(03)00804-1","article-title":"Q fever: A biological weapon in your backyard","volume":"3","author":"Madariaga","year":"2003","journal-title":"Lancet. Infect. Dis."},{"key":"ref_4","doi-asserted-by":"crossref","first-page":"463","DOI":"10.4269\/ajtmh.1940.s1-20.463","article-title":"Rickettsia Diaporica and American Q Fever","volume":"1","author":"Cox","year":"1940","journal-title":"Am. J. Trop. Med."},{"key":"ref_5","first-page":"71","article-title":"Vaccination against Q fever","volume":"47","author":"Smadel","year":"1948","journal-title":"Am. J. Hyg."},{"key":"ref_6","doi-asserted-by":"crossref","first-page":"518","DOI":"10.1128\/CMR.12.4.518","article-title":"Q fever","volume":"12","author":"Maurin","year":"1999","journal-title":"Clin. Microbiol. Rev."},{"key":"ref_7","first-page":"98","article-title":"Studies on Q fever in man","volume":"69","author":"Benenson","year":"1956","journal-title":"Trans. Assoc. Am. Physicians"},{"key":"ref_8","first-page":"54","article-title":"Q fever in California. I. Observations on vaccination of human beings","volume":"52","author":"Meiklejohn","year":"1950","journal-title":"Am. J. Hyg."},{"key":"ref_9","doi-asserted-by":"crossref","first-page":"591","DOI":"10.1093\/milmed\/129.7.591","article-title":"Recurrent reaction of site of Q fever vaccination in a sensitized person","volume":"129","author":"Bell","year":"1964","journal-title":"Mil. Med."},{"key":"ref_10","doi-asserted-by":"crossref","first-page":"161","DOI":"10.1016\/j.jinf.2014.03.008","article-title":"Immunogenicity of the Q fever skin test","volume":"69","author":"Schoffelen","year":"2014","journal-title":"J. Infect."},{"key":"ref_11","doi-asserted-by":"crossref","first-page":"741","DOI":"10.4049\/jimmunol.88.6.741","article-title":"Antigens of Coxiella burnetii. I. Extraction of antigens with non-aqueous organic solvents","volume":"88","author":"Ormsbee","year":"1962","journal-title":"J. Immunol."},{"key":"ref_12","doi-asserted-by":"crossref","first-page":"87","DOI":"10.2105\/AJPH.52.1.87","article-title":"Intradermal sensitivity testing in man with a purified vaccine for Q fever","volume":"52","author":"Lackman","year":"1962","journal-title":"Am. J. Public Health Nations Health"},{"key":"ref_13","doi-asserted-by":"crossref","first-page":"404","DOI":"10.4049\/jimmunol.92.3.404","article-title":"The influence of phase on the protective potency of Q fever vaccine","volume":"92","author":"Ormsbee","year":"1964","journal-title":"J. Immunol."},{"key":"ref_14","first-page":"557","article-title":"An intradermal sensitivity test for Q fever in man","volume":"36","author":"Lackman","year":"1959","journal-title":"Arch. Inst. Pasteur Tunis"},{"key":"ref_15","unstructured":"(1984). Q fever: Antigens and vaccines. Lancet, 2, 1435\u20131436."},{"key":"ref_16","doi-asserted-by":"crossref","first-page":"1091","DOI":"10.1128\/iai.35.3.1091-1102.1982","article-title":"Biological and immunological properties of Coxiella burnetii vaccines in C57BL\/10ScN endotoxin-nonresponder mice","volume":"35","author":"Williams","year":"1982","journal-title":"Infect. Immun."},{"key":"ref_17","doi-asserted-by":"crossref","first-page":"1505","DOI":"10.1128\/CVI.00119-08","article-title":"Low-Dose Priming before Vaccination with the Phase I Chloroform-Methanol Residue Vaccine against Q Fever Enhances Humoral and Cellular Immune Responses to Coxiella burnetii","volume":"15","author":"Waag","year":"2008","journal-title":"Clin. Vaccine Immunol."},{"key":"ref_18","doi-asserted-by":"crossref","first-page":"2623","DOI":"10.1016\/S0264-410X(02)00176-7","article-title":"Comparative efficacy and immunogenicity of Q fever chloroform:methanol residue (CMR) and phase I cellular (Q-Vax) vaccines in cynomolgus monkeys challenged by aerosol","volume":"20","author":"Waag","year":"2002","journal-title":"Vaccine"},{"key":"ref_19","doi-asserted-by":"crossref","first-page":"145","DOI":"10.4049\/jimmunol.89.1.145","article-title":"Antigenic and Skin-Reactive Properties of Fractions of Coxiella Burnetii","volume":"89","author":"Anacker","year":"1962","journal-title":"J. Immunol."},{"key":"ref_20","first-page":"4","article-title":"Study of the antigenic structure of Coxiella burnetii. I. Extraction of Phase I antigenic component by means of trichloroacetic acid","volume":"6","author":"Brezina","year":"1962","journal-title":"Acta Virol."},{"key":"ref_21","doi-asserted-by":"crossref","first-page":"310","DOI":"10.1139\/m56-036","article-title":"Phase variation of the Nine Mile and other strains of Rickettsia burneti","volume":"2","author":"Stoker","year":"1956","journal-title":"Can. J. Microbiol."},{"key":"ref_22","doi-asserted-by":"crossref","first-page":"1144","DOI":"10.1128\/iai.55.5.1144-1150.1987","article-title":"Comparative virulence of intra- and interstrain lipopolysaccharide variants of Coxiella burnetii in the guinea pig model","volume":"55","author":"Moos","year":"1987","journal-title":"Infect. Immun."},{"key":"ref_23","doi-asserted-by":"crossref","first-page":"133","DOI":"10.1080\/21505594.2019.1575715","article-title":"Comparative virulence of diverse Coxiella burnetii strains","volume":"10","author":"Long","year":"2019","journal-title":"Virulence"},{"key":"ref_24","doi-asserted-by":"crossref","first-page":"8372","DOI":"10.4049\/jimmunol.179.12.8372","article-title":"Mechanisms of vaccine-induced protective immunity against Coxiella burnetii infection in BALB\/c mice","volume":"179","author":"Zhang","year":"2007","journal-title":"J. Immunol."},{"key":"ref_25","doi-asserted-by":"crossref","unstructured":"Beare, P.A., Jeffrey, B.M., Long, C.M., Martens, C.M., and Heinzen, R.A. (2018). Genetic mechanisms of Coxiella burnetii lipopolysaccharide phase variation. PLoS Pathog., 14.","DOI":"10.1371\/journal.ppat.1006922"},{"key":"ref_26","first-page":"143","article-title":"Report of a field study with Q fever vaccine","volume":"79","author":"Vivona","year":"1964","journal-title":"Am. J. Hyg."},{"key":"ref_27","doi-asserted-by":"crossref","unstructured":"Wisseman, C.L. (1964). Progress Report on the Development of Q Fever Vaccines. Mil. Med., 389\u2013392.","DOI":"10.1093\/milmed\/129.5.389"},{"key":"ref_28","first-page":"703","article-title":"Experience in mass immunization of humans with the M-44 live vaccine against Q-fever. 2. Skin and oral routes of immunization","volume":"10","author":"Genig","year":"1965","journal-title":"Vopr. Virusol."},{"key":"ref_29","doi-asserted-by":"crossref","first-page":"777","DOI":"10.1128\/am.27.4.777-783.1974","article-title":"Production of a potent vaccine from the attenuated M-44 strain of Coxiella burneti","volume":"27","author":"Robinson","year":"1974","journal-title":"Appl. Microbiol."},{"key":"ref_30","doi-asserted-by":"crossref","unstructured":"Pittman, P.R., and Plotkin, S.A. (2018). Biodefense and Special Pathogen Vaccines. Plotkin\u2019s Vaccines, 149\u2013160.e147.","DOI":"10.1016\/B978-0-323-35761-6.00012-2"},{"key":"ref_31","doi-asserted-by":"crossref","first-page":"704","DOI":"10.5694\/j.1326-5377.1994.tb125909.x","article-title":"Vaccine prophylaxis of Q fever. A follow-up study of the efficacy of Q-Vax (CSL) 1985-1990","volume":"160","author":"Ackland","year":"1994","journal-title":"Med. J. Aust."},{"key":"ref_32","doi-asserted-by":"crossref","unstructured":"Sellens, E., Bosward, K.L., Willis, S., Heller, J., Cobbold, R., Comeau, J.L., Norris, J.M., Dhand, N.K., and Wood, N. (2018). Frequency of Adverse Events Following Q Fever Immunisation in Young Adults. Vaccines, 6.","DOI":"10.3390\/vaccines6040083"},{"key":"ref_33","doi-asserted-by":"crossref","first-page":"2617","DOI":"10.1016\/j.vaccine.2013.03.062","article-title":"Implementation of a Q fever vaccination program for high-risk patients in the Netherlands","volume":"31","author":"Isken","year":"2013","journal-title":"Vaccine"},{"key":"ref_34","doi-asserted-by":"crossref","first-page":"726","DOI":"10.3389\/fmicb.2014.00726","article-title":"Vaccination against Q fever for biodefense and public health indications","volume":"5","author":"Ruiz","year":"2014","journal-title":"Front. Microbiol."},{"key":"ref_35","doi-asserted-by":"crossref","first-page":"e222","DOI":"10.1016\/S1473-3099(21)00382-0","article-title":"Biodefence research two decades on: Worth the investment?","volume":"21","author":"Long","year":"2021","journal-title":"Lancet Infect. Dis."},{"key":"ref_36","doi-asserted-by":"crossref","first-page":"4430","DOI":"10.1073\/pnas.0812074106","article-title":"Host cell-free growth of the Q fever bacterium Coxiella burnetii","volume":"106","author":"Omsland","year":"2009","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"ref_37","doi-asserted-by":"crossref","first-page":"249","DOI":"10.1007\/978-94-007-4315-1_13","article-title":"Genetic manipulation of Coxiella burnetii","volume":"984","author":"Beare","year":"2012","journal-title":"Adv. Exp. Med. Biol."},{"key":"ref_38","doi-asserted-by":"crossref","first-page":"401","DOI":"10.1086\/589862","article-title":"Correlates of Vaccine-Induced Immunity","volume":"47","author":"Plotkin","year":"2008","journal-title":"Clin. Infect. Dis."},{"key":"ref_39","doi-asserted-by":"crossref","first-page":"641","DOI":"10.1128\/iai.31.2.641-645.1981","article-title":"Role of antibody in Coxiella burnetii infection","volume":"31","author":"Humphres","year":"1981","journal-title":"Infect. Immun."},{"key":"ref_40","first-page":"422","article-title":"Search for correlates of resistance to virulent challenge in mice immunized with Coxiella burnetii","volume":"21","author":"Brezina","year":"1977","journal-title":"Acta Virol."},{"key":"ref_41","doi-asserted-by":"crossref","first-page":"91","DOI":"10.1007\/978-94-007-4315-1_5","article-title":"Components of protective immunity","volume":"984","author":"Zhang","year":"2012","journal-title":"Adv. Exp. Med. Biol."},{"key":"ref_42","doi-asserted-by":"crossref","unstructured":"Shannon, J.G., Cockrell, D.C., Takahashi, K., Stahl, G.L., and Heinzen, R.A. (2009). Antibody-mediated immunity to the obligate intracellular bacterial pathogen Coxiella burnetii is Fc receptor- and complement-independent. BMC Immunol., 10.","DOI":"10.1186\/1471-2172-10-26"},{"key":"ref_43","doi-asserted-by":"crossref","first-page":"3019","DOI":"10.1128\/IAI.00101-10","article-title":"Role of CD4+ and CD8+ T Cells in Clearance of Primary Pulmonary Infection with Coxiella burnetii","volume":"78","author":"Read","year":"2010","journal-title":"Infect. Immun."},{"key":"ref_44","doi-asserted-by":"crossref","first-page":"e00602-17","DOI":"10.1128\/IAI.00602-17","article-title":"Both Major Histocompatibility Complex Class I (MHC-I) and MHC-II Molecules Are Required, while MHC-I Appears To Play a Critical Role in Host Defense against Primary Coxiella burnetii Infection","volume":"86","author":"Buttrum","year":"2018","journal-title":"Infect. Immun."},{"key":"ref_45","doi-asserted-by":"crossref","unstructured":"Ledbetter, L., Cherla, R., Chambers, C., Zhang, Y., Mitchell, W.J., and Zhang, G. (2019). MHC-II-restricted, CD4(+) T cell-dependent and -independent mechanisms are required for vaccine-induced protective immunity against Coxiella burnetii. Infect. Immun.","DOI":"10.1128\/IAI.00824-19"},{"key":"ref_46","doi-asserted-by":"crossref","first-page":"1546","DOI":"10.3389\/fmicb.2020.01546","article-title":"T-Bet Controls Susceptibility of Mice to Coxiella burnetii Infection","volume":"11","author":"Mezouar","year":"2020","journal-title":"Front. Microbiol."},{"key":"ref_47","doi-asserted-by":"crossref","first-page":"624","DOI":"10.1093\/infdis\/jiz146","article-title":"Chemokine Receptor 7 Is Essential for Coxiella burnetii Whole-Cell Vaccine-Induced Cellular Immunity but Dispensable for Vaccine-Mediated Protective Immunity","volume":"220","author":"Chen","year":"2019","journal-title":"J. Infect. Dis."},{"key":"ref_48","doi-asserted-by":"crossref","first-page":"3245","DOI":"10.1128\/IAI.01767-06","article-title":"T cells are essential for bacterial clearance, and gamma interferon, tumor necrosis factor alpha, and B cells are crucial for disease development in Coxiella burnetii infection in mice","volume":"75","author":"Andoh","year":"2007","journal-title":"Infect. Immun."},{"key":"ref_49","doi-asserted-by":"crossref","first-page":"398","DOI":"10.1038\/s41577-019-0145-4","article-title":"The evolving role of T-bet in resistance to infection","volume":"19","author":"Pritchard","year":"2019","journal-title":"Nat. Rev. Immunol."},{"key":"ref_50","doi-asserted-by":"crossref","first-page":"38","DOI":"10.1038\/s41541-021-00296-6","article-title":"Contributions of lipopolysaccharide and the type IVB secretion system to Coxiella burnetii vaccine efficacy and reactogenicity","volume":"6","author":"Long","year":"2021","journal-title":"NPJ Vaccines"},{"key":"ref_51","doi-asserted-by":"crossref","first-page":"194","DOI":"10.1128\/iai.19.1.194-198.1978","article-title":"Cell-mediated immune responses of guinea pigs to an inactivated phase I Coxiella burnetii vaccine","volume":"19","author":"Kishimoto","year":"1978","journal-title":"Infect. Immun."},{"key":"ref_52","doi-asserted-by":"crossref","first-page":"601","DOI":"10.1128\/iai.15.2.601-607.1977","article-title":"Fat of Coxiella burnetti in macrophages from immune guinea pigs","volume":"15","author":"Kishimoto","year":"1977","journal-title":"Infect. Immun."},{"key":"ref_53","doi-asserted-by":"crossref","first-page":"6809","DOI":"10.1016\/j.vaccine.2012.09.017","article-title":"Mice immunized with bone marrow-derived dendritic cells stimulated with recombinant Coxiella burnetii Com1 and Mip demonstrate enhanced bacterial clearance in association with a Th1 immune response","volume":"30","author":"Xiong","year":"2012","journal-title":"Vaccine"},{"key":"ref_54","doi-asserted-by":"crossref","first-page":"275","DOI":"10.1017\/S0950268800059458","article-title":"Vaccine prophylaxis of abattoir-associated Q fever: Eight years\u2019 experience in Australian abattoirs","volume":"104","author":"Marmion","year":"1990","journal-title":"Epidemiol. Infect."},{"key":"ref_55","doi-asserted-by":"crossref","first-page":"129","DOI":"10.1128\/CVI.00613-12","article-title":"Long-Term immune responses to Coxiella burnetii after vaccination","volume":"20","author":"Kersh","year":"2013","journal-title":"Clin. Vaccine Immunol."},{"key":"ref_56","doi-asserted-by":"crossref","first-page":"1067","DOI":"10.1093\/qjmed\/hcs119","article-title":"An analysis of Q fever patients 6 years after an outbreak in Newport, Wales, UK","volume":"105","author":"Islam","year":"2012","journal-title":"QJM Int. J. Med."},{"key":"ref_57","doi-asserted-by":"crossref","first-page":"62","DOI":"10.1017\/S0950268812000404","article-title":"Time-course of antibody responses against Coxiella burnetii following acute Q fever","volume":"141","author":"Teunis","year":"2013","journal-title":"Epidemiol. Infect."},{"key":"ref_58","doi-asserted-by":"crossref","first-page":"281","DOI":"10.1099\/00222615-19-3-281","article-title":"Antibody responses in acute and chronic Q fever and in subjects vaccinated against Q fever","volume":"19","author":"Worswick","year":"1985","journal-title":"J. Med. Microbiol."},{"key":"ref_59","first-page":"73","article-title":"Antibody response in man following a small intradermal inoculation with Coxiella burnetii phase I vaccine","volume":"23","author":"Peacock","year":"1979","journal-title":"Acta Virol."},{"key":"ref_60","doi-asserted-by":"crossref","first-page":"1411","DOI":"10.1016\/S0140-6736(84)91617-9","article-title":"Vaccine prophylaxis of abattoir-associated Q fever","volume":"2","author":"Marmion","year":"1984","journal-title":"Lancet"},{"key":"ref_61","doi-asserted-by":"crossref","first-page":"7084","DOI":"10.1016\/j.vaccine.2017.10.088","article-title":"Q-Vax Q fever vaccine failures, Victoria, Australia 1994-2013","volume":"35","author":"Bond","year":"2017","journal-title":"Vaccine"},{"key":"ref_62","first-page":"243","article-title":"Immunogenicity and protective ability of corpuscular and soluble vaccines prepared from different Coxiella burnetii phase I strains","volume":"39","year":"1995","journal-title":"Acta Virol."},{"key":"ref_63","doi-asserted-by":"crossref","first-page":"5640","DOI":"10.1128\/IAI.00851-09","article-title":"Coxiella burnetii isolates cause genogroup-specific virulence in mouse and guinea pig models of acute Q fever","volume":"77","author":"Andoh","year":"2009","journal-title":"Infect. Immun."},{"key":"ref_64","first-page":"134","article-title":"The value of skin test in Q fever convalescents and vaccinees as indicator of antigen exposure and inducer of antibody recall","volume":"28","author":"Schramek","year":"1984","journal-title":"Acta Virol."},{"key":"ref_65","doi-asserted-by":"crossref","first-page":"507","DOI":"10.1111\/j.1365-2249.1993.tb08226.x","article-title":"Variation in interferon-gamma responses to Coxiella burnetii antigens with lymphocytes from vaccinated or naturally infected subjects","volume":"94","author":"Izzo","year":"1993","journal-title":"Clin. Exp. Immunol."},{"key":"ref_66","doi-asserted-by":"crossref","first-page":"478","DOI":"10.1016\/j.jinf.2016.01.004","article-title":"Altered interferon-\u03b3 response in patients with Q-fever fatigue syndrome","volume":"72","author":"Keijmel","year":"2016","journal-title":"J. Infect."},{"key":"ref_67","doi-asserted-by":"crossref","first-page":"209.e9","DOI":"10.1016\/j.cmi.2016.11.008","article-title":"Intact interferon-\u03b3 response against Coxiella burnetii by peripheral blood mononuclear cells in chronic Q fever","volume":"23","author":"Schoffelen","year":"2017","journal-title":"Clin. Microbiol. Infect."},{"key":"ref_68","doi-asserted-by":"crossref","first-page":"642","DOI":"10.1111\/1469-0691.12423","article-title":"A combination of interferon-gamma and interleukin-2 production by Coxiella burnetii-stimulated circulating cells discriminates between chronic Q fever and past Q fever","volume":"20","author":"Schoffelen","year":"2014","journal-title":"Clin. Microbiol. Infect."},{"key":"ref_69","doi-asserted-by":"crossref","first-page":"844","DOI":"10.1128\/IAI.72.2.844-852.2004","article-title":"Identification and Cloning of Immunodominant Antigens of Coxiella burnetii","volume":"72","author":"Zhang","year":"2004","journal-title":"Infect. Immun."},{"key":"ref_70","doi-asserted-by":"crossref","first-page":"510","DOI":"10.1111\/j.1749-6632.2003.tb07420.x","article-title":"Identification and cloning potentially protective antigens of Coxiella burnetii using sera from mice experimentally infected with Nine Mile phase I","volume":"990","author":"Zhang","year":"2003","journal-title":"Ann. N. Y. Acad. Sci."},{"key":"ref_71","doi-asserted-by":"crossref","first-page":"M110.006304","DOI":"10.1074\/mcp.M110.006304","article-title":"Profiling the humoral immune response of acute and chronic Q fever by protein microarray","volume":"10","author":"Vigil","year":"2011","journal-title":"Mol. Cell. Proteom."},{"key":"ref_72","doi-asserted-by":"crossref","first-page":"453","DOI":"10.1007\/s11427-013-4472-6","article-title":"Protein array of Coxiella burnetii probed with Q fever sera","volume":"56","author":"Wang","year":"2013","journal-title":"Sci. China Life Sci."},{"key":"ref_73","doi-asserted-by":"crossref","first-page":"2259","DOI":"10.1002\/pmic.201000064","article-title":"Genome-wide profiling of humoral immune response to Coxiella burnetii infection by protein microarray","volume":"10","author":"Vigil","year":"2010","journal-title":"Proteomics"},{"key":"ref_74","doi-asserted-by":"crossref","first-page":"1771","DOI":"10.1128\/CVI.00300-08","article-title":"Candidate Antigens for Q Fever Serodiagnosis Revealed by Immunoscreening of a Coxiella burnetii Protein Microarray","volume":"15","author":"Beare","year":"2008","journal-title":"Clin. Vaccine Immunol."},{"key":"ref_75","doi-asserted-by":"crossref","unstructured":"Xiong, X., Wang, X., Wen, B., Graves, S., and Stenos, J. (2012). Potential serodiagnostic markers for Q fever identified in Coxiella burnetiiby immunoproteomic and protein microarray approaches. BMC Microbiol., 12.","DOI":"10.1186\/1471-2180-12-35"},{"key":"ref_76","doi-asserted-by":"crossref","unstructured":"Xiong, X., Qi, Y., Jiao, J., Gong, W., Duan, C., and Wen, B. (2014). Exploratory study on Th1 epitope-induced protective immunity against Coxiella burnetii infection. PLoS ONE, 9.","DOI":"10.1371\/journal.pone.0087206"},{"key":"ref_77","first-page":"1580","article-title":"Identification of Coxiella burnetii CD8+ T-Cell Epitopes and Delivery by Attenuated Listeria monocytogenes as a Vaccine Vector in a C57BL\/6 Mouse Model","volume":"215","author":"Xiong","year":"2016","journal-title":"J. Infect. Dis."},{"key":"ref_78","doi-asserted-by":"crossref","first-page":"13311","DOI":"10.1038\/s41598-020-69327-x","article-title":"Novel multiparameter correlates of Coxiella burnetii infection and vaccination identified by longitudinal deep immune profiling","volume":"10","author":"Reeves","year":"2020","journal-title":"Sci. Rep."},{"key":"ref_79","doi-asserted-by":"crossref","first-page":"585","DOI":"10.1189\/jlb.0113014","article-title":"Ly6 family proteins in neutrophil biology","volume":"94","author":"Lee","year":"2013","journal-title":"J. Leukoc. Biol."},{"key":"ref_80","doi-asserted-by":"crossref","first-page":"207","DOI":"10.3389\/fimmu.2019.00207","article-title":"Promiscuous Coxiella burnetii CD4 Epitope Clusters Associated With Human Recall Responses Are Candidates for a Novel T-Cell Targeted Multi-Epitope Q Fever Vaccine","volume":"10","author":"Scholzen","year":"2019","journal-title":"Front. Immunol."},{"key":"ref_81","doi-asserted-by":"crossref","unstructured":"Scholzen, A., Richard, G., Moise, L., Hartman, E., Bleeker-Rovers, C.P., Reeves, P.M., Raju Paul, S., Martin, W.D., De Groot, A.S., and Poznansky, M.C. (2019). Coxiella burnetii Epitope-Specific T-Cell Responses in Patients with Chronic Q Fever. Infect. Immun., 87.","DOI":"10.1128\/IAI.00213-19"},{"key":"ref_82","doi-asserted-by":"crossref","first-page":"130","DOI":"10.1196\/annals.1355.021","article-title":"Protective immunity against Q fever induced with a recombinant P1 antigen fused with HspB of Coxiella burnetii","volume":"1063","author":"Li","year":"2005","journal-title":"Ann. N. Y. Acad. Sci."},{"key":"ref_83","doi-asserted-by":"crossref","unstructured":"Gilkes, A.P., Albin, T.J., Manna, S., Supnet, M., Ruiz, S., Tom, J., Badten, A.J., Jain, A., Nakajima, R., and Felgner, J. (2019). Tuning Subunit Vaccines with Novel TLR Triagonist Adjuvants to Generate Protective Immune Responses against Coxiella burnetii. J. Immunol., ji1900991.","DOI":"10.4049\/jimmunol.1900991"},{"key":"ref_84","doi-asserted-by":"crossref","first-page":"370","DOI":"10.1111\/j.1749-6632.1990.tb42243.x","article-title":"Antigenic structure of Coxiella burnetii. A comparison of lipopolysaccharide and protein antigens as vaccines against Q fever","volume":"590","author":"Williams","year":"1990","journal-title":"Ann. N. Y. Acad. Sci."},{"key":"ref_85","doi-asserted-by":"crossref","first-page":"359","DOI":"10.1128\/iai.48.2.359-365.1985","article-title":"Lipopolysaccharide variation in Coxiella burnetti: Intrastrain heterogeneity in structure and antigenicity","volume":"48","author":"Hackstadt","year":"1985","journal-title":"Infect. Immun."},{"key":"ref_86","doi-asserted-by":"crossref","first-page":"4909","DOI":"10.4049\/jimmunol.1201622","article-title":"Development of a lipopolysaccharide-targeted peptide mimic vaccine against Q fever","volume":"189","author":"Peng","year":"2012","journal-title":"J. Immunol."},{"key":"ref_87","doi-asserted-by":"crossref","first-page":"529","DOI":"10.1093\/infdis\/116.5.529","article-title":"Bioassay of endotoxin: Correlation between pyrogenicity for rabbits and lethality for chick embryos","volume":"116","author":"Milner","year":"1966","journal-title":"J. Infect. Dis."},{"key":"ref_88","first-page":"410","article-title":"Histological changes in mouse liver and spleen caused by different Coxiella burnetii antigenic preparations","volume":"29","author":"Kokorin","year":"1985","journal-title":"Acta Virol."},{"key":"ref_89","doi-asserted-by":"crossref","first-page":"851","DOI":"10.1128\/iai.51.3.851-858.1986","article-title":"Characterization of a phase I Coxiella burnetii chloroform-methanol residue vaccine that induces active immunity against Q fever in C57BL\/10 ScN mice","volume":"51","author":"Williams","year":"1986","journal-title":"Infect. Immun."},{"key":"ref_90","first-page":"499","article-title":"Onset and duration of immunity in guinea pigs and mice induced with different Q fever vaccines","volume":"30","author":"Votruba","year":"1986","journal-title":"Acta Virol."},{"key":"ref_91","doi-asserted-by":"crossref","first-page":"87","DOI":"10.19182\/remvt.9404","article-title":"Immunization of dogs with Q fever vaccines: Comparison of phase I, II and phase I CMR Coxiella burnetii vaccines","volume":"46","author":"Williams","year":"1993","journal-title":"Rev. Elev. Med. Vet. Pays. Trop."},{"key":"ref_92","doi-asserted-by":"crossref","first-page":"1779","DOI":"10.1016\/S0264-410X(97)00107-2","article-title":"Comparative efficacy of a Coxiella burnetii chloroform:methanol residue (CMR) vaccine and a licensed cellular vaccine (Q-Vax) in rodents challenged by aerosol","volume":"15","author":"Waag","year":"1997","journal-title":"Vaccine"},{"key":"ref_93","doi-asserted-by":"crossref","first-page":"1251","DOI":"10.1128\/iai.61.4.1251-1258.1993","article-title":"Safety and immunogenicity in human volunteers of a chloroform-methanol residue vaccine for Q fever","volume":"61","author":"Fries","year":"1993","journal-title":"Infect. Immun."},{"key":"ref_94","doi-asserted-by":"crossref","first-page":"6076","DOI":"10.1016\/j.vaccine.2019.08.041","article-title":"Enhanced protection against Q fever in BALB\/c mice elicited by immunization of chloroform-methanol residue of Coxiella burnetii via intratracheal inoculation","volume":"37","author":"Feng","year":"2019","journal-title":"Vaccine"},{"key":"ref_95","doi-asserted-by":"crossref","first-page":"83","DOI":"10.1038\/s41577-020-00479-7","article-title":"A guide to vaccinology: From basic principles to new developments","volume":"21","author":"Pollard","year":"2021","journal-title":"Nat. Rev. Immunol."},{"key":"ref_96","first-page":"327","article-title":"Protective immunity induced by 67 K outer membrane protein of phase I Coxiella burnetii in mice and guinea pigs","volume":"38","author":"Zhang","year":"1994","journal-title":"Acta Virol."},{"key":"ref_97","doi-asserted-by":"crossref","first-page":"541","DOI":"10.3168\/jds.2015-9628","article-title":"Effect of a phase I Coxiella burnetii inactivated vaccine on body temperature and milk yield in dairy cows","volume":"99","author":"Schulze","year":"2016","journal-title":"J. Dairy Sci."},{"key":"ref_98","doi-asserted-by":"crossref","first-page":"88","DOI":"10.1111\/j.1749-6632.1992.tb19633.x","article-title":"Vaccines against coxiellosis and Q fever. Development of a chloroform:methanol residue subunit of phase I Coxiella burnetti for the immunization of animals","volume":"653","author":"Williams","year":"1992","journal-title":"Ann. N. Y. Acad. Sci."},{"key":"ref_99","first-page":"79","article-title":"Q fever vaccines for animals","volume":"267","author":"Schmeer","year":"1987","journal-title":"Zent. Bakteriol. Mikrobiol. Hyg. A"},{"key":"ref_100","doi-asserted-by":"crossref","first-page":"4392","DOI":"10.1016\/j.vaccine.2005.04.010","article-title":"Effect of vaccination with phase I and phase II Coxiella burnetii vaccines in pregnant goats","volume":"23","author":"Souriau","year":"2005","journal-title":"Vaccine"},{"key":"ref_101","doi-asserted-by":"crossref","first-page":"188","DOI":"10.1111\/j.1469-0691.2008.02220.x","article-title":"Efficiency of a phase 1 vaccine for the reduction of vaginal Coxiella burnetii shedding in a clinically affected goat herd","volume":"15","author":"Rousset","year":"2009","journal-title":"Clin. Microbiol. Infect."},{"key":"ref_102","unstructured":"Simoes, J.C.C., Anastacio, S.F., and de Silva, G.J. (2017). Fever Vaccination in Ruminants: A Critical Review. The Principles and Practice of Q Fever, Nova Science Publishers."},{"key":"ref_103","doi-asserted-by":"crossref","first-page":"2309","DOI":"10.1128\/JB.188.7.2309-2324.2006","article-title":"Genetic diversity of the Q fever agent, Coxiella burnetii, assessed by microarray-based whole-genome comparisons","volume":"188","author":"Beare","year":"2006","journal-title":"J. Bacteriol."},{"key":"ref_104","doi-asserted-by":"crossref","first-page":"775","DOI":"10.1128\/iai.49.3.775-779.1985","article-title":"Correlation of plasmid type and disease caused by Coxiella burnetii","volume":"49","author":"Samuel","year":"1985","journal-title":"Infect. Immun."},{"key":"ref_105","first-page":"269","article-title":"Differentiation of Coxiella burnetii isolates by analysis of restriction-endonuclease-digested DNA separated by SDS-PAGE","volume":"137","author":"Hendrix","year":"1991","journal-title":"J. Gen. Microbiol."},{"key":"ref_106","doi-asserted-by":"crossref","first-page":"337","DOI":"10.1128\/iai.52.1.337-340.1986","article-title":"Antigenic variation in the phase I lipopolysaccharide of Coxiella burnetii isolates","volume":"52","author":"Hackstadt","year":"1986","journal-title":"Infect. Immun."},{"key":"ref_107","doi-asserted-by":"crossref","first-page":"34","DOI":"10.1080\/21645515.2016.1239668","article-title":"Current prospects and future challenges for nasal vaccine delivery","volume":"13","author":"Yusuf","year":"2017","journal-title":"Hum. Vaccines Immunother."},{"key":"ref_108","doi-asserted-by":"crossref","first-page":"eabh0755","DOI":"10.1126\/scitranslmed.abh0755","article-title":"Intranasal ChAdOx1 nCoV-19\/AZD1222 vaccination reduces viral shedding after SARS-CoV-2 D614G challenge in preclinical models","volume":"13","author":"Purushotham","year":"2021","journal-title":"Sci. Transl. Med."},{"key":"ref_109","doi-asserted-by":"crossref","first-page":"e00178-19","DOI":"10.1128\/IAI.00178-19","article-title":"Coxiella burnetii Intratracheal Aerosol Infection Model in Mice, Guinea Pigs, and Nonhuman Primates","volume":"87","author":"Gregory","year":"2019","journal-title":"Infect. Immun."},{"key":"ref_110","doi-asserted-by":"crossref","first-page":"16013","DOI":"10.1038\/npjvaccines.2016.13","article-title":"First vaccine approval under the FDA Animal Rule","volume":"1","author":"Beasley","year":"2016","journal-title":"NPJ Vaccines"}],"container-title":["Pathogens"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.mdpi.com\/2076-0817\/10\/10\/1223\/pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,10,11]],"date-time":"2025-10-11T07:03:13Z","timestamp":1760166193000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.mdpi.com\/2076-0817\/10\/10\/1223"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,9,22]]},"references-count":110,"journal-issue":{"issue":"10","published-online":{"date-parts":[[2021,10]]}},"alternative-id":["pathogens10101223"],"URL":"https:\/\/doi.org\/10.3390\/pathogens10101223","relation":{},"ISSN":["2076-0817"],"issn-type":[{"value":"2076-0817","type":"electronic"}],"subject":[],"published":{"date-parts":[[2021,9,22]]}}}